Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Post
Print
Kalpesh Jain
CEO
Krishgen Biosystems
Poster(s):
(532) ELISA-Based Neutralizing Antibody (NAb) Detection as a Fit-for-Purpose Alternative to Cell-Based Assays for Biotherapeutic Immunogenicity Assessment
Thursday, April 16, 2026
2:30 PM - 3:30 PM
US ET
(749) Decoupling Drug Exposure, Binding ADA, and Functional Neutralization in Anti–PD-L1 Therapy Using Orthogonal ELISA Immunogenicity Assessment
Saturday, April 18, 2026
11:30 AM - 12:30 PM
US ET
